India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
18/09/2026 04:38
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India Sept 18 (Reuters) - Dr Reddy's Laboratories REDY.NS said on Friday it signed a deal with Takeda Pharmaceutical Company 4502.T for the promotion and distribution of the Qdenga dengue vaccine in India.
(Reporting by Kashish Tandon in Bengaluru; Editing by Sonia Cheema)
((Kashish.Tandon@thomsonreuters.com; 8800437922;))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)